I
IntraLase Corporation
Leader in the first step of lasik surgery, the most common means of surgical vision correction
About IntraLase Corporation
IntraLase Corporation was established as a spin-out from the University of Michigan in 1997 by Dr. Ron Kurtz, an ophthalmology resident, and Dr. Tibor Juhasz, a laser physicist. Their collaboration began after a lab accident involving a femtosecond laser injury, which revealed the laser's capacity for extremely precise tissue incisions without collateral damage. This observation led them to develop a femtosecond laser for ophthalmic surgery, specifically to improve the LASIK procedure.
The company focused on commercializing an ultra-fast laser system that replaces the hand-held microkeratome blade traditionally used to create the corneal flap in the initial step of LASIK surgery. This blade-free method, marketed as the IntraLase Method or IntraLASIK, utilizes rapid, low-energy laser pulses to create microscopic bubbles at a specific depth within the cornea, forming a precisely shaped flap. This approach offered surgeons enhanced control over flap diameter, depth, and architecture, which improved safety profiles and visual outcomes for patients.
IntraLase operated in the ophthalmic surgery market, serving eye care practitioners and surgeons performing refractive and corneal procedures. Its business model centered on the sale of the IntraLase FS laser system, related software, and the associated disposable devices required for each procedure. The company also invested heavily in research and development to expand the applications of its technology into other corneal surgeries, such as corneal transplants (IntraLase Enabled Keratoplasty).
Initially funded by venture capital, IntraLase relocated to Irvine, California, in 1998 to be closer to the center of the ophthalmic industry. The company went public with an initial public offering in October 2004. A significant milestone was its acquisition by Advanced Medical Optics (AMO) in 2007 for approximately $808 million in cash. This transaction integrated IntraLase's femtosecond laser technology with AMO's broader portfolio of refractive technologies. Subsequently, Abbott Laboratories acquired AMO in 2009.
Source: Dealroom company dataNews
Open roles
IntraLase Corporation in the Irvine ecosystem
The IntraLase Corporation office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A2 investors entered at this stage
- EVEDF Ventures
Brentwood Investments
Series B and later5 investors entered at this stage
Venture Investors Health Fund
Brentwood Associates
Domain Associates
InterWest Partners
Meritech Capital
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about IntraLase Corporation on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See IntraLase Corporation on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.
